Early detection of cancer saves lives! With over 610,000 cancer deaths in the U.S. each
year, many from types with no FDA-approved screenings, EPISEEK is making progress in detecting early-stage cancers that were previously undetectable.
Unlock the life-saving power of Precision Epigemonics early cancer detection tool. EPISEEK identifies over 20 prevalent cancer types, many of which have no other early detection test available.
Once you order your test, a member of our clinical team will reach out to arrange your blood test visit. Once the lab results are in, we will set up a follow up.
EPISEEK: Early Cancer Detection Tool Test and Medical Consult
Detecting the Undectable
When it comes to cancer, early detection is key to saving lives! With 610,000+ cancer deaths in the U.S. each year, most of which stemming from cancer types with no FDA-approved screening options, EPISEEK is making revolutionary strides in detecting cancers that have been previously undetectable in early stages.
The EPISEEK liquid biopsy blood test is intended to be used as a complementary tool to established cancer screening assessments. However in some cases, especially for cancer types that have no previously established screening test and are notoriously hard to detect, it may be the only warning sign currently available for providers.